Today: 10 November 2025
Subscribe

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Strive (ASST) Stock Skyrockets 40% on Bitcoin Bet – Wild Rally Spurs Bold Forecasts

Strive (ASST) Stock Skyrockets 40% on Bitcoin Bet – Wild Rally Spurs Bold Forecasts

ASST Stock Soars on Crypto Comeback Strive, Inc. (ASST) is kicking off the week with a bang. By Monday morning (Oct. 27, 2025), ASST shares had leapt roughly 25% in pre-market trading to about $1.37, building on Friday’s big jump ts2.tech. The stock briefly touched $1.50 overnight – a 40% leap from Friday’s close – before settling around the mid-$1.30s range ts2.tech. This rapid rise caps a dramatic turnaround for Strive’s stock, which was languishing below $0.80 just days ago ts2.tech. Year-to-date, ASST is now up over 120%, far outpacing the broader market ts2.tech. What’s driving the frenzy? The surge
27 October 2025
 ·  ·  ·  ·  · 
Midweek Double Whammy: Fed Decision & Big Tech Earnings Collide Amid Trump-Xi Trade Truce

Midweek Double Whammy: Fed Decision & Big Tech Earnings Collide Amid Trump-Xi Trade Truce

Markets Soar to Record Highs on Fed Hopes and Trade Optimism Investors head into this pivotal week riding a wave of market euphoria. Last Friday (Oct. 24), U.S. stocks roared to new record highs across the board. The Dow Jones Industrial Average jumped about 400 points (+0.8%) to close at an all-time peak, while the S&P 500 climbed 0.8% and the Nasdaq Composite 1.0%, both also notching record closes ts2.tech. All three major indexes gained roughly 2% over the course of the week investopedia.com, capping a rally fueled by encouraging economic news. The catalyst: fresh evidence that inflation is cooling.
27 October 2025
 ·  ·  ·  · 
Bitfarms (BITF) Stock Whipsaws Amid Bitcoin Boom and $500M AI Pivot – Will the Rally Resume?

Bitfarms (BITF) Stock Whipsaws Amid Bitcoin Boom and $500M AI Pivot – Will the Rally Resume?

BITF Stock Soars, Then Swoons in Volatile October Bitfarms shareholders have experienced whiplash this month. The stock surged to a 52-week high of nearly $6.20 on October 14 amid crypto market euphoria, then swiftly tumbled about 40% over the next week ts2.tech. By October 22, BITF hit an intraday low of $3.94, capping a five-session losing streak ts2.tech. It did stabilize toward week’s end – as of the market close on Oct. 24, Bitfarms hovered around the $4.00–$4.10 level ts2.tech ts2.tech, indicating some support emerging just above $4. Despite these swings, Bitfarms has delivered staggering gains in 2025. Even after
26 October 2025
 ·  ·  ·  ·  · 
Nvidia Stock Soars on AI Mega-Deals – Will NVDA Hit $300 Amid Boom and Bubble Fears?

Nvidia Stock Soars on AI Mega-Deals – Will NVDA Hit $300 Amid Boom and Bubble Fears?

AI Boom Propels Nvidia to Historic Highs Nvidia’s meteoric stock surge in 2025 showcases how central the company has become to the AI revolution. In early October, NVDA briefly became the world’s most valuable publicly traded company when its market capitalization topped $4.5 trillion – surpassing even Apple and Microsoft ts2.tech. That milestone capped a massive run: Nvidia’s shares have soared over 1,300% since late 2022, as the market wagers that its high-performance graphics processors (GPUs) will be the indispensable engines of modern AI reuters.com reuters.com. This confidence is rooted in eye-popping fundamentals. For the quarter ended July 2025, Nvidia reported
26 October 2025
 ·  ·  ·  ·  · 
Opendoor’s Wild 2025 Ride: 1600% Meme Surge, New CEO & Crypto Pivot – What’s Next for OPEN Stock?

Opendoor’s Wild 2025 Ride: 1600% Meme Surge, New CEO & Crypto Pivot – What’s Next for OPEN Stock?

Latest News & Recent Developments (Late October 2025) In the past few days, Opendoor’s stock has whipsawed on macro news. On Friday, Oct. 24, OPEN soared over 13% to $7.97 after a cooler-than-expected inflation report fueled optimism that the Fed will cut interest rates soon markets.financialcontent.com markets.financialcontent.com. Real estate-related stocks rallied broadly on the prospect of lower borrowing costs, and Opendoor – highly sensitive to interest rates – was a big beneficiary, jumping to its highest levels in a week markets.financialcontent.com. This rebound followed a mid-month pullback. As recently as October 22, Opendoor had dipped to around $6.82 per share
26 October 2025
 ·  ·  ·  ·  · 
GSI Technology (GSIT) Stock Explodes 200% on AI Chip Breakthrough – What’s Next for This Small-Cap?

GSI Technology (GSIT) Stock Explodes 200% on AI Chip Breakthrough – What’s Next for This Small-Cap?

Cornell AI Chip Breakthrough Ignites a Buying Frenzy GSI Technology’s “Gemini-I” APU – a novel Associative Processing Unit that performs AI computations directly in memory – received independent validation from a Cornell University-led study unveiled on Oct 20 at the MICRO’25 conference ts2.tech. Researchers confirmed GSI’s chip can deliver performance on par with a high-end NVIDIA GPU for certain artificial intelligence tasks, while using roughly 98% less energy ts2.tech. In large-scale tests of retrieval-augmented generation (a challenging AI workload), the Gemini-I APU achieved throughput comparable to an NVIDIA A6000 GPU but with a tiny fraction of the power draw ts2.tech.
26 October 2025
 ·  ·  ·  ·  · 
700% Surge: BitMine Immersion’s $13B Ethereum Gamble – Boom or Bubble?

700% Surge: BitMine Immersion’s $13B Ethereum Gamble – Boom or Bubble?

BMNR’s Wild Stock Ride in 2025 Few stocks have seen a rollercoaster like BMNR this year. The share price languished under $2 late last year, then exploded in mid-2025 as BitMine’s crypto pivot captivated the market ts2.tech. By early July, BMNR hit an intraday high of $161 after a major equity raise stoked optimism ts2.tech. Since then, volatility has been the norm: the 52-week range spans from under $4 to $161 ts2.tech. In recent weeks, BMNR’s day-to-day moves have closely tracked the crypto market. After hovering around $59–$60 in early October, the stock jumped 11.6% on Oct. 6 to close at
26 October 2025
 ·  ·  ·  ·  · 
Arm Stock Soars on AI Buzz: Price Hits $170 as Analysts Hike Targets

Arm Stock Soars on AI Buzz: Price Hits $170 as Analysts Hike Targets

ARM Stock Climbs on AI Momentum Arm’s stock has been on a tear thanks to a flurry of positive news in the semiconductor and AI space. The Cambridge, U.K.-based chip design firm saw its shares jump about 4% on Monday after unveiling an expansion of its licensing program for AI-focused chips reuters.com. The stock ended the week around $170.68, up roughly 2.5% over five days marketbeat.com and hovering near its highest levels since Arm’s blockbuster IPO last year. Up to this Monday’s close, Arm’s stock was up over 34% for 2025 reuters.com – outpacing many peer semiconductor stocks – as
26 October 2025
 ·  ·  ·  ·  · 
BBAI Stock Skyrockets on Latest AI-Defense Deals – Can the Rally Last?

BBAI Stock Skyrockets on Latest AI-Defense Deals – Can the Rally Last?

Stock Rally and Volatility Insights BigBear.ai (BBAI) shares have been on a tear in 2025, fueled by defense-AI contracts and broader AI enthusiasm. The stock began the year as a sub-$4 penny stock and roughly doubled to ~$8–9 by mid-October ts2.tech. A major catalyst was the Tsecond partnership announcement on Oct. 13, which sent BBAI up ~22% in one day ts2.tech. At that peak the stock briefly touched $9.39 before profit-taking set in ts2.tech. By Oct. 22 it had pulled back into the mid-$7 range, marking a ~20% retracement from its recent high ts2.tech.Traders note BigBear.ai is extremely volatile. Multiple
26 October 2025
 ·  ·  ·  ·  · 
Intel Stock Soars on AI Hype and $15B Lifeline – Can the Rally Last?

Intel Stock Soars on AI Hype and $15B Lifeline – Can the Rally Last?

Surging Stock on Turnaround Hopes Intel shares have mounted a stunning comeback in 2025, riding optimism that the embattled chipmaker can regain its footing in the AI era. The stock has climbed roughly 90% year-to-date, closing around $38 per share at last week’s end – territory it hasn’t seen in nearly two years ts2.tech. Just this Friday (Oct. 24), Intel spiked as much as 7.8% intraday after its quarterly earnings beat, hitting an 18-month high before settling up about 2% on the day reuters.com reuters.com. By comparison, industry darlings Nvidia and AMD – whose stocks have also surged on the
26 October 2025
 ·  ·  ·  ·  · 
Ford Stock Rockets 10% on Q3 Earnings – Can EV Blues and Recall Woes Stop the Rally?

Ford Stock Rockets 10% on Q3 Earnings – Can EV Blues and Recall Woes Stop the Rally?

Ford’s Q3 report showed the strength of its core businesses. Wall Street cheered the upside surprise: revenue of $50.5B and EPS of $0.45 easily topped forecasts reuters.com. In after-hours trading on Oct. 23 the stock leapt again, taking the price to about $13.68 by Oct. 24 ca.investing.com. TechStock² notes that this rally broke above Ford’s long-standing trading range (~$10–13), with momentum indicators still healthy ts2.tech. The market seems to be rewarding Ford’s focus on profitable growth areas, notably commercial fleets and full-size trucks. Indeed, Ford’s “Blue” (gasoline) vehicles and its Ford Pro fleet division drove most of the gains, while
26 October 2025
 ·  ·  ·  ·  · 
Recursion (RXRX) Stock Surges on AI Drug Discovery Hype – What’s Driving the Rally?

Recursion (RXRX) Stock Surges on AI Drug Discovery Hype – What’s Driving the Rally?

AI-Driven “TechBio” Strategy Recursion’s narrative centers on its AI-enhanced drug discovery platform. Founded in 2013 in Salt Lake City, Recursion has spent years building RecursionOS, a giant database of cellular images and chemical data powered by machine learning biotechhealthx.com. The company invested heavily in bio-automation infrastructure (like its NVIDIA-based supercomputers) to train AI models on billions of data points. Its strategy is twofold: use this tech to generate proprietary drug candidates while partnering with pharma giants to co-develop new drugs. As one biotech newsletter notes, Recursion “has focused on fewer but more strategically important deals” with big pharma, securing hefty
26 October 2025
 ·  ·  ·  ·  · 
1 … 44 45 46 47 48 … 175
Go toTop